date:Feb 27, 2013
utions for infants, children and adults with genetic disorders that affect how food is processed by the body; and a minority investment in the U.S. company Accera, which specializes in medical foods intended for the clinical dietary management of mild to moderate Alzheimers disease.
In 2012, Nestle also entered into a joint venture called Nutrition Science Partners Ltd. to develop nutritional and medicinal products derived from plants to address gastrointestinal disorders.